[1] ZHU J, TAN Z, HOLLIS-HANSEN K, et al. Epidemiological trends in colorectal cancer in China: An ecological study [J]. Digestive Diseases and Sciences, 2017,62(1): 235-243.
[2] ANSA B, COUGHLIN S, ALEMA-MENSAH E, etal. Evaluation of colorectal cancer incidence trends inthe United States (2000–2014) [J]. Journal of ClinicalMedicine, 2018, 7(2): 22.
[3] CUNNINGHAM D, ATKIN W, LENZ H, et al. Colorectal cancer [J]. Lancet, 2010, 375(9719): 1030-1047.
[4] GEISS G K, BUMGARNER R E, BIRDITT B, etal. Direct multiplexed measurement of gene expressionwith color-coded probe pairs [J]. Nature Biotechnology,2008, 26(3): 317-325.
[5] OZSOLAK F, MILOS P M. RNA sequencing: Advances, challenges and opportunities [J]. Nature Reviews Genetics, 2011, 12(2): 87-98.
[6] SHETH J, ARNOLDO A, ZHONG Y, et al. Sarcomasubgrouping by detection of fusion transcripts usingNanoString nCounter technology [J]. Pediatric and Developmental Pathology, 2019, 22(3): 205-213.
[7] HYEON J, CHO S Y, HONG M E, et al. NanoStringnCounter? approach in breast cancer: A comparativeanalysis with quantitative real-time polymerase chainreaction, in situ hybridization, and immunohistochemistry [J]. Journal of Breast Cancer, 2017, 20(3): 286-296.
[8] TSANG H F, XUE V W, KOH S P, et al. NanoString, anovel digital color-coded barcode technology: Currentand future applications in molecular diagnostics [J].Expert Review of Molecular Diagnostics, 2017, 17(1):95-103.
[9] TANG Z, LI C, KANG B, et al. GEPIA: A web serverfor cancer and normal gene expression profiling andinteractive analyses [J]. Nucleic Acids Research, 2017,45(W1): W98-W102.
[10] LU J, KSENDZOVSKY A, YANG C, et al. CNTFreceptor subunit α as a marker for glioma tumorinitiating cells and tumor grade: Laboratory investigation [J]. Journal of Neurosurgery, 2012, 117(6): 1022-1031.
[11] MA D, JING X, SHEN B, et al. Leukemia inhibitoryfactor receptor negatively regulates the metastasis ofpancreatic cancer cells in vitro and in vivo [J]. Oncology Reports, 2016, 36(2): 827-836.
[12] LUO Q, WANG C, JIN G, et al. LIFR functions as ametastasis suppressor in hepatocellular carcinoma bynegatively regulating phosphoinositide 3-kinase/AKTpathway [J]. Carcinogenesis, 2015, 36(10): 1201-1212.
[13] GREGORY K J, MORIN S M, SCHNEIDER S S.Regulation of early growth response 2 expression bysecreted frizzled related protein 1 [J]. BMC Cancer,2017, 17(1): 473.
[14] BOLDRUP L, GU X, COATES P J, et al. Gene expression changes in tumor free tongue tissue adjacent totongue squamous cell carcinoma [J]. Oncotarget, 2017,8(12): 19389-19402.
[15] FISCHER H, STENLING R, RUBIO C, et al. Colorectal carcinogenesis is associated with stromal expressionof COL11A1 and COL5A2 [J]. Carcinogenesis, 2001,22(6): 875-878.
[16] GALV′AN J A, GARC′IA-MART′INEZ J, V′AZQUEZVILLA F, et al. Validation of COL11A1/procollagen11A1 expression in TGF-β 1-activated immortalisedhuman mesenchymal cells and in stromal cells of human colon adenocarcinoma [J]. BMC Cancer, 2014, 14:867.
[17] CHEN L, LU D, SUN K, et al. Identification ofbiomarkers associated with diagnosis and prognosis ofcolorectal cancer patients based on integrated bioinformatics analysis [J]. Gene, 2019, 692: 119-125.
[18] JIANG H, GE F, HU B, et al. rs35301225 polymorphism in miR-34a promotes development of humancolon cancer by deregulation of 3’UTR in E2F1 in Chinese population [J]. Cancer Cell International, 2017,17: 39.
[19] SHANTHA KUMARA H M C, GAITA D J, MIYAGAKI H, et al. Minimally invasive colorectal resectionis associated with significantly elevated levels of plasmamatrix metalloproteinase 3 (MMP-3 ) during the firstmonth after surgery which may promote the growth ofresidual metastases [J]. Surgical Endoscopy and OtherInterventional Techniques, 2014, 28(12): 3322-3328.
[20] JUNG Y, JUN S, LEE S H, et al. Wnt2 complementsWnt/β-catenin signaling in colorectal cancer [J]. Oncotarget, 2015, 6(35): 37257-37268.
[21] KRAMER N, SCHMOELLERL J, UNGER C, et al.Autocrine WNT2 signaling in fibroblasts promotes colorectal cancer progression [J]. Oncogene, 2017, 36(39):5460-5472.
[22] HUANG R, MO D, WU J, et al. CD133 expression correlates with clinicopathologic features and poorprognosis of colorectal cancer patients: An updatedmeta-analysis of 37 studies [J]. Medicine, 2018, 97(23):e10446.
[23] MESCI A, TAEB S, HUANG X, et al. Pea3 expression promotes the invasive and metastatic potential ofcolorectal carcinoma [J]. World Journal of Gastroenterology, 2014, 20(46): 17376-17387.
[24] HUANG H. Matrix metalloproteinase-9 (MMP-9 ) asa cancer biomarker and MMP-9 biosensors: Recentadvances [J]. Sensors, 2018, 18(10): 3249.
[25] LIANG S, CHANG L. Serum matrixmetalloproteinase-9 level as a biomarker for colorectal cancer: A diagnostic meta-analysis [J].Biomarkers in Medicine, 2018, 12(4): 393-402.
[26] POLI V, FAGNOCCHI L, FASCIANI A, et al. MYC -driven epigenetic reprogramming favors the onset oftumorigenesis by inducing a stem cell-like state [J]. Nature Communications, 2018, 9: 1024.
[27] SCHICK M, HABRINGER S, NILSSON J A, et al.Pathogenesis and therapeutic targeting of aberrantMYC expression in haematological cancers [J]. BritishJournal of Haematology, 2017, 179(5): 724-738.
[28] YU T, WANG L, LI W, et al. Downregulation of miR-491-5p promotes gastric cancer metastasis by regulating SNAIL and FGFR4 [J]. Cancer Science, 2018,109(5): 1393-1403.
[29] ARABPOUR M, RASOLMALI R, TALEI A, et al.Granzyme B production by activated B cells derivedfrom breast cancer-draining lymph nodes [J]. Molecular Immunology, 2019, 114: 172-178.
[30] SUMTER T F, XIAN L, HUSO T, et al. The highmobility group A1 (HMGA1) transcriptome in cancer and development [J]. Current Molecular Medicine,2016, 16(4): 353-393.
[31] GAO Y, NAN X, SHI X, et al. SREBP1 promotes theinvasion of colorectal cancer accompanied upregulationof MMP7 expression and NF-κB pathway activation[J]. BMC Cancer, 2019, 19(1): 685.
[32] YANG L, SONG X, ZHU J, et al. Tumor suppressor microRNA-34a inhibits cell migration and invasionby targeting MMP-2/MMP-9/FNDC3B in esophagealsquamous cell carcinoma [J]. International Journal ofOncology, 2017, 51(1): 378-388.
[33] FENG D, ZHAO T, YAN K, et al. Gonadotropins promote human ovarian cancer cell migration and invasionvia a cyclooxygenase 2-dependent pathway [J]. Oncology Reports, 2017, 38(2): 1091-1098.
